Createrna was invited to participate in the Chinese Pharmaceutical Innovation Investment Forum

To further promote the deep integration of global capital and boost the development of our pharmaceutical industry, the China Pharmaceutical Promotion Council (PhIRDA) will host the 2021 China Pharmaceutical Innovation Investment Forum during the 39th JP Morgan Healthcare Conference.

The forum will focus on the new trends and trends of global investment and financing, and select a number of high-quality innovative enterprises to show the achievements of China's pharmaceutical innovation, promote international cooperation in the field of pharmaceutical innovation, and jointly build a new model of the pharmaceutical industry. As one of the grand events in the pharmaceutical industry, the forum will deeply focus on industrial policies, global pharmaceutical research and development trends and investment and financing trends, comprehensively discuss the development trend of global pharmaceutical innovation, and discuss the new development of biomedical investment cooperation.

图1 中国医药创新投资论坛

The forum invited the leaders of the Pharmaceutical Promotion Association, domestic outstanding scientists, entrepreneurs, authoritative experts in the financial sector and investors and other important guests. A number of high-quality roadshow enterprises at home and abroad will be selected to show their pharmaceutical innovation achievements.

Participating enterprises in the forum include Beigene, Rongchang Bio, Zejing Bio, Arbele and other leading innovative pharmaceutical enterprises at home and abroad. As the representative of innovative pharmaceutical enterprises in the forum, Langlai Technology was invited to attend the China Pharmaceutical Innovation Investment Forum and give a public speech, which will bring the theme road show to the colleagues in the industry: the research and development of highly selective P2X3 antagonist for the treatment of refractory chronic cough.